Globus Medical (GMED) Total Current Liabilities (2011 - 2026)
Globus Medical's (GMED) quarterly Total Current Liabilities came in at $479.3 million in Q2 2026, up 12.88% on a YoY basis from $424.7 million in Q2 2025, and down 0.65% quarter-over-quarter from $482.5 million in Q1 2026.
Analysis
Globus Medical (GMED) Total Current Liabilities (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has reported Total Current Liabilities for 16 consecutive years, with $479.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 12.88% year-over-year to $479.3 million; the trailing twelve-month figure through Jun 2026 stood at $479.3 million (up 12.88% YoY), and the FY2025 full-year result was $498.5 million, down 41.76% from the prior year.
- Total Current Liabilities slipped to $479.3 million in Q2 2026 per GMED's latest filing, from $482.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $855.9 million in Q4 2024 and bottomed at $141.5 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $429.2 million across 5 years, with a median of $426.7 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities soared 411.63% in 2024, then sank 51.08% in 2025.
- Over 5 years, Total Current Liabilities stood at $159.2 million in 2022, then surged by 146.44% to $392.3 million in 2023, then jumped by 118.15% to $855.9 million in 2024, then tumbled by 41.76% to $498.5 million in 2025, then declined by 3.84% to $479.3 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $479.3 million, $482.5 million, and $498.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Globus Medical | 9.94 Bn | 9.35 Bn | 548.17 Mn | 479.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 479.35 Mn |
| Mar 31, 2026 | 482.46 Mn |
| Dec 31, 2025 | 498.50 Mn |
| Sep 30, 2025 | 465.96 Mn |
| Jun 30, 2025 | 424.66 Mn |
| Mar 31, 2025 | 384.70 Mn |
| Dec 31, 2024 | 855.91 Mn |
| Sep 30, 2024 | 818.07 Mn |
| Jun 30, 2024 | 794.15 Mn |
| Mar 31, 2024 | 786.32 Mn |
| Dec 31, 2023 | 392.35 Mn |
| Sep 30, 2023 | 428.72 Mn |
| Jun 30, 2023 | 155.22 Mn |
| Mar 31, 2023 | 167.55 Mn |
| Dec 31, 2022 | 159.20 Mn |
| Sep 30, 2022 | 145.26 Mn |
| Jun 30, 2022 | 146.02 Mn |
| Mar 31, 2022 | 141.49 Mn |
| Dec 31, 2021 | 140.16 Mn |
| Sep 30, 2021 | 122.53 Mn |